Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study

ABSTRACT: BACKGROUND: In January 2017, the Dutch cervical cancer screening programme transitioned from cytomorphological to primary high-risk HPV (hrHPV) DNA screening, including the introduction of self-sampling, for women aged between 30 and 60 years. The Netherlands was the first country to switc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Med
Egile Nagusiak: Aitken, Clare A., van Agt, Heleen M. E., Siebers, Albert G., van Kemenade, Folkert J., Niesters, Hubert G. M., Melchers, Willem J. G., Vedder, Judith E. M., Schuurman, Rob, van den Brule, Adriaan J. C., van der Linden, Hans C., Hinrichs, John W. J., Molijn, Anco, Hoogduin, Klaas J., van Hemel, Bettien M., de Kok, Inge M. C. M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6907114/
https://ncbi.nlm.nih.gov/pubmed/31829241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1460-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak